Relmada Therapeutics Statistics
Total Valuation
RLMD has a market cap or net worth of $10.72 million. The enterprise value is -$34.19 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
RLMD has 33.19 million shares outstanding. The number of shares has increased by 0.21% in one year.
Current Share Class | 33.19M |
Shares Outstanding | 33.19M |
Shares Change (YoY) | +0.21% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 7.90% |
Owned by Institutions (%) | 25.50% |
Float | 30.57M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.27 |
P/TBV Ratio | 0.30 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.45
Current Ratio | 4.45 |
Quick Ratio | 4.36 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -132.33% and return on invested capital (ROIC) is -86.75%.
Return on Equity (ROE) | -132.33% |
Return on Assets (ROA) | -73.14% |
Return on Invested Capital (ROIC) | -86.75% |
Return on Capital Employed (ROCE) | -236.14% |
Revenue Per Employee | n/a |
Profits Per Employee | -$4.70M |
Employee Count | 17 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.08% in the last 52 weeks. The beta is 0.41, so RLMD's price volatility has been lower than the market average.
Beta (5Y) | 0.41 |
52-Week Price Change | -92.08% |
50-Day Moving Average | 0.29 |
200-Day Moving Average | 1.91 |
Relative Strength Index (RSI) | 58.58 |
Average Volume (20 Days) | 386,970 |
Short Selling Information
The latest short interest is 1.62 million, so 4.89% of the outstanding shares have been sold short.
Short Interest | 1.62M |
Short Previous Month | 1.49M |
Short % of Shares Out | 4.89% |
Short % of Float | 5.31% |
Short Ratio (days to cover) | 4.07 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -83.89M |
Pretax Income | -86.76M |
Net Income | -79.98M |
EBITDA | n/a |
EBIT | -83.89M |
Earnings Per Share (EPS) | -$2.65 |
Full Income Statement Balance Sheet
The company has $44.91 million in cash and n/a in debt, giving a net cash position of $44.91 million or $1.35 per share.
Cash & Cash Equivalents | 44.91M |
Total Debt | n/a |
Net Cash | 44.91M |
Net Cash Per Share | $1.35 |
Equity (Book Value) | 35.52M |
Book Value Per Share | 1.18 |
Working Capital | 35.50M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -51.76M |
Capital Expenditures | n/a |
Free Cash Flow | -51.76M |
FCF Per Share | -$1.56 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RLMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.21% |
Shareholder Yield | -0.21% |
Earnings Yield | -746.01% |
FCF Yield | -482.76% |
Analyst Forecast
The average price target for RLMD is $4.25, which is 1,241.12% higher than the current price. The consensus rating is "Hold".
Price Target | $4.25 |
Price Target Difference | 1,241.12% |
Analyst Consensus | Hold |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -25.92% |
Stock Forecasts Stock Splits
The last stock split was on September 30, 2019. It was a reverse split with a ratio of 0.25:1.
Last Split Date | Sep 30, 2019 |
Split Type | Reverse |
Split Ratio | 0.25:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |